BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

376 related articles for article (PubMed ID: 20002024)

  • 1. Phosphatidylethanol: normalization during detoxification, gender aspects and correlation with other biomarkers and self-reports.
    Wurst FM; Thon N; Aradottir S; Hartmann S; Wiesbeck GA; Lesch O; Skala K; Wolfersdorf M; Weinmann W; Alling C
    Addict Biol; 2010 Jan; 15(1):88-95. PubMed ID: 20002024
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phosphatidylethanol as a sensitive and specific biomarker: comparison with gamma-glutamyl transpeptidase, mean corpuscular volume and carbohydrate-deficient transferrin.
    Hartmann S; Aradottir S; Graf M; Wiesbeck G; Lesch O; Ramskogler K; Wolfersdorf M; Alling C; Wurst FM
    Addict Biol; 2007 Mar; 12(1):81-4. PubMed ID: 17407500
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PHosphatidylethanol (PEth) concentrations in blood are correlated to reported alcohol intake in alcohol-dependent patients.
    Aradottir S; Asanovska G; Gjerss S; Hansson P; Alling C
    Alcohol Alcohol; 2006; 41(4):431-7. PubMed ID: 16624837
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The usefulness of direct ethanol metabolites in assessing alcohol intake in nonintoxicated male patients in an emergency room setting.
    Kip MJ; Spies CD; Neumann T; Nachbar Y; Alling C; Aradottir S; Weinmann W; Wurst FM
    Alcohol Clin Exp Res; 2008 Jul; 32(7):1284-91. PubMed ID: 18540912
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of sialic acid index of plasma apolipoprotein J and phosphatidylethanol during alcohol detoxification--a pilot study.
    Wurst FM; Thon N; Weinmann W; Tippetts S; Marques P; Hahn JA; Alling C; Aradottir S; Hartmann S; Lakshman R
    Alcohol Clin Exp Res; 2012 Feb; 36(2):251-7. PubMed ID: 21933198
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Validity of carbohydrate-deficient transferrin (%CDT), gamma-glutamyltransferase (gamma-GT) and mean corpuscular erythrocyte volume (MCV) as biomarkers for chronic alcohol abuse: a study in patients with alcohol dependence and liver disorders of non-alcoholic and alcoholic origin.
    Hock B; Schwarz M; Domke I; Grunert VP; Wuertemberger M; Schiemann U; Horster S; Limmer C; Stecker G; Soyka M
    Addiction; 2005 Oct; 100(10):1477-86. PubMed ID: 16185209
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sex differences of carbohydrate-deficient transferrin, gamma-glutamyltransferase, and mean corpuscular volume in alcohol-dependent patients.
    Mundle G; Munkes J; Ackermann K; Mann K
    Alcohol Clin Exp Res; 2000 Sep; 24(9):1400-5. PubMed ID: 11003206
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Carbohydrate deficient transferrin, gammaglutamyl transferase and mean corpuscular volume in the evaluation of recent alcohol intake in excessive drinkers].
    Glasinovic JC; Lobos X; Scrivanti M; Severín MC; Quiroga T; Moncada C
    Rev Med Chil; 2001 Apr; 129(4):375-81. PubMed ID: 11413989
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical characteristics of carbohydrate-deficient transferrin (%disialotransferrin) measured by HPLC: sensitivity, specificity, gender effects, and relationship with other alcohol biomarkers.
    Bergström JP; Helander A
    Alcohol Alcohol; 2008; 43(4):436-41. PubMed ID: 18411243
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phosphatidylethanol is superior to carbohydrate-deficient transferrin and γ-glutamyltransferase as an alcohol marker and is a reliable estimate of alcohol consumption level.
    Walther L; de Bejczy A; Löf E; Hansson T; Andersson A; Guterstam J; Hammarberg A; Asanovska G; Franck J; Söderpalm B; Isaksson A
    Alcohol Clin Exp Res; 2015 Nov; 39(11):2200-8. PubMed ID: 26503066
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combinations of carbohydrate-deficient transferrin, mean corpuscular erythrocyte volume, gamma-glutamyltransferase, homocysteine and folate increase the significance of biological markers in alcohol dependent patients.
    Rinck D; Frieling H; Freitag A; Hillemacher T; Bayerlein K; Kornhuber J; Bleich S
    Drug Alcohol Depend; 2007 Jun; 89(1):60-5. PubMed ID: 17234365
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Monitoring of the alcohol biomarkers PEth, CDT and EtG/EtS in an outpatient treatment setting.
    Helander A; Péter O; Zheng Y
    Alcohol Alcohol; 2012; 47(5):552-7. PubMed ID: 22691387
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phosphatidylethanol in blood as a marker of ethanol consumption in healthy volunteers: comparison with other markers.
    Varga A; Hansson P; Lundqvist C; Alling C
    Alcohol Clin Exp Res; 1998 Nov; 22(8):1832-7. PubMed ID: 9835304
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Blood phosphatidylethanol as a marker of alcohol abuse: levels in alcoholic males during withdrawal.
    Hansson P; Caron M; Johnson G; Gustavsson L; Alling C
    Alcohol Clin Exp Res; 1997 Feb; 21(1):108-10. PubMed ID: 9046381
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of the combined marker GGT-CDT and the conventional laboratory markers of alcohol abuse in heavy drinkers, moderate drinkers and abstainers.
    Hietala J; Koivisto H; Anttila P; Niemelä O
    Alcohol Alcohol; 2006; 41(5):528-33. PubMed ID: 16799164
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of carbohydrate-deficient transferrin (CDT) and a combination of GGT and CDT (GGT-CDT) to assess heavy alcohol consumption in traffic medicine.
    Bianchi V; Ivaldi A; Raspagni A; Arfini C; Vidali M
    Alcohol Alcohol; 2010; 45(3):247-51. PubMed ID: 20118108
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phosphatidylethanol in blood (B-PEth): a marker for alcohol use and abuse.
    Isaksson A; Walther L; Hansson T; Andersson A; Alling C
    Drug Test Anal; 2011 Apr; 3(4):195-200. PubMed ID: 21438164
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Objective diagnosis of alcohol abuse: compared values of carbohydrate-deficient transferrin (CDT), gamma-glutamyl transferase (GGT), and mean corpuscular volume (MCV).
    Reynaud M; Schellenberg F; Loisequx-Meunier MN; Schwan R; Maradeix B; Planche F; Gillet C
    Alcohol Clin Exp Res; 2000 Sep; 24(9):1414-9. PubMed ID: 11003208
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment of alcohol consumption among hepatitis C-positive people receiving opioid maintenance treatment using direct ethanol metabolites and self-report: a pilot study.
    Wurst FM; Haber PS; Wiesbeck G; Watson B; Wallace C; Whitfield JB; Halter C; Weinmann W; Conigrave KM
    Addict Biol; 2008 Sep; 13(3-4):416-22. PubMed ID: 17711559
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phosphatidylethanol Compared with Other Blood Tests as a Biomarker of Moderate Alcohol Consumption in Healthy Volunteers: A Prospective Randomized Study.
    Kechagias S; Dernroth DN; Blomgren A; Hansson T; Isaksson A; Walther L; Kronstrand R; Kågedal B; Nystrom FH
    Alcohol Alcohol; 2015 Jul; 50(4):399-406. PubMed ID: 25882743
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.